Drawing for CONSILIUM CARE

USPTO serial 79299543

CONSILIUM CARE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
O'BRIEN, JENNIFER LYNN
Law office
TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CONSILIUM CARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Computer programs for use in data networks to assist patients and doctors concerning the treatment of illnesses; application software in the medical field, in particular in the fields of patient support and consultation; application software for the capture of medical data on patients for the purposes of remote monitoring of patients and coordination of their care; application software for data entry, data processing and reporting for medical purposes; downloadable and non-downloadable software for data entry, data processing and the exchange of data and patient information, including the results of patient reports and assessments of clinical treatment outcomes by computer, in particular in the field of oncologyACTIVE
035Input of information on the use of pharmaceuticals and other medical treatmentsACTIVE
038Transmission of information via electronic communication networks; transmission of information, in particular information for the purposes of medical advice and care; provision of access to databases; provision of access to databases in the medical field; provision of access to Internet platforms in the medical fieldACTIVE
041Training; provision of online publications and online seminars; coaching; all services in this class in the field of medicine and support and advice for patients and health professionalsACTIVE
042Scientific and medical research; provision of application software for the capture of medical data on patients for the purposes of remote patient monitoring and healthcare coordination using data processing devices, web-based computers, SMS (short message services) and mobile devices; provision of software as a service [SaaS]; all services in this category in the field of medicine and support and advice for patients and medical staffACTIVE
044Medical services, in particular medical advice and care, provided by means of application software and the Internet; observation of patients; advice and information services concerning pharmaceuticals and other forms of medical treatment, provided by means of application software and the Internet; preparation of medical health reports; all services in this class in the field of medicine and support and advice for patients and medical staffACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 13, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED
Oct 10, 2022FINTFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 20, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 20, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 30, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 11, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 11, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 12, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
Sep 20, 2021MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 20, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 20, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED
Mar 28, 2021RFNTREFUSAL PROCESSED BY IB
Mar 8, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 8, 2021RFRRREFUSAL PROCESSED BY MPU
Mar 3, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 2, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2021DOCKASSIGNED TO EXAMINER
Dec 15, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Dec 11, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 10, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance